Skip to content
Trial Eligibility
Menu

Biology of Young Lung Cancer Study: The YOUNG LUNG Study

NCT05265429

This study is recruiting at 2 US sites in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The purpose of this research study is to learn more about lung cancer (NSCLC or SCLC) diagnosed in adults at ages 45 or younger.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Non Small Cell Lung Cancer
  • Small Cell Lung Carcinoma
  • NUT Carcinoma

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
15 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
Dana-Farber Cancer Institute
Last updated on ClinicalTrials.gov
October 29, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Massachusetts · 2

  • Dana-Farber Cancer Institute · Boston, MA
  • Massachusetts General Hospital · Boston, MA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.